Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by production of autoantibody directly responding to pathogenic antigen 180 (BP180) within the dermal-epidermal junction (DEJ)1, 2. This evidence concerns the gene COL17A1 and bullous pemphigoid.